1-3 of 3
Su Yan, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic Efficacy and Cure Of Sensitive and T315I Pan-Resistant Human Ph+ Leukemia In Mice Using a TCR-Like Antibody To WT1/HLA-A0201 Alone, Or In Combination With Tyrosine Kinase Inhibitors

Leonid Dubrovsky, MD, Elliott Brea, Dmitry Pankov, MD, Nicholas Veomett, Tao Dao, MD/PhD, Su Yan, PhD, Cheng Liu, PhD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 855.
https://doi.org/10.1182/blood.V122.21.855.855
Published: 2013
Journal Articles

Native and Fc Enhanced Therapeutic Human Monoclonal Antibodies Targeting the Intracellular WT1 Oncogene Product in Leukemia.

Nicholas Veomett, Tao Dao, MD, PhD, Dmitry Pankov, MD, Su Yan, PhD, Richard J. O'Reilly, MD, Cheng Liu, PhD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2599.
https://doi.org/10.1182/blood.V120.21.2599.2599
Published: 2012
Journal Articles

A Cytotoxic Human Monoclonal Antibody Recognizing Cell Surface WT1 Peptide/HLA-A2 Complexes

David A. Scheinberg, MD, PhD, Tao Dao, MD, PhD, Su Yan, PhD, Liang Zhou, PhD, Tatyana Korontsvit, Victoriya Zakhaleva, Michael Curcio, Cheng Liu, PhD
Journal: Blood
Blood (2011) 118 (21): 1677.
https://doi.org/10.1182/blood.V118.21.1677.1677
Published: 2011